Search

Search Constraints

You searched for: Author/Creator Dahut, William L.

Search Results

1. A phase I study of TRC105 anti‐endoglin (CD105) antibody in metastatic castration‐resistant prostate cancer. (8th June 2015)

2. Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations. Issue 1 (4th December 2018)

5. Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer. (23rd October 2020)

8. Phase II clinical trial of cediranib in patients with metastatic castration‐resistant prostate cancer. (18th February 2013)

9. Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration‐resistant prostate cancer. (19th February 2016)